Valneva SE Pref. Stock Euronext Paris
Stocks
VLAP
FR0011472943
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| Market Cap | 421M 485M 394M 361M 681M 46.24B 690M 4.61B 1.81B 23.1B 1.82B 1.78B 76.89B | P/E 2026 * |
-6.05x | P/E 2027 * | 5.31x |
|---|---|---|---|---|---|
| Enterprise Value | 549M 633M 514M 470M 888M 60.29B 900M 6.02B 2.36B 30.12B 2.38B 2.32B 100B | EV / Sales 2026 * |
3.62x | EV / Sales 2027 * | 1.64x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Valneva SE Pref.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 29/07/2021 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20/12/2023 | |
James Sulat
BRD | Director/Board Member | 75 | 07/03/2013 |
| Chairman | 65 | 20/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 489M | |
| +0.93% | -1.43% | +1.61% | +14.93% | 48.57B | |
| +0.26% | +2.93% | +439.43% | +567.38% | 41.95B | |
| -1.53% | -2.25% | +30.95% | +5.99% | 38.85B | |
| +0.69% | +2.40% | +10.48% | +75.87% | 37.24B | |
| +2.47% | +8.33% | +15.16% | +48.37% | 30.67B | |
| -0.47% | +1.16% | +35.93% | +124.67% | 16.41B | |
| +2.31% | -0.49% | - | - | 16.1B | |
| +0.29% | +1.81% | +4.92% | +18.60% | 13.97B | |
| -1.43% | -2.63% | +3.70% | -35.93% | 12.62B | |
| Average | +0.15% | -0.30% | +67.77% | +102.48% | 28.48B | |
| Weighted average by Cap. | +0.31% | +0.39% | +88.54% | +128.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152M 175M 142M 130M 246M 16.67B 249M 1.66B 653M 8.33B 657M 643M 27.71B | 294M 339M 275M 252M 475M 32.28B 482M 3.22B 1.26B 16.13B 1.27B 1.24B 53.68B |
| Net income | -66.01M -76.07M -61.81M -56.54M -107M -7.25B -108M -723M -284M -3.62B -286M -279M -12.05B | 77.68M 89.52M 72.74M 66.54M 126M 8.53B 127M 851M 334M 4.26B 336M 329M 14.18B |
| Net Debt | 128M 148M 120M 110M 207M 14.05B 210M 1.4B 550M 7.02B 554M 542M 23.37B | 60.02M 69.16M 56.2M 51.41M 97.05M 6.59B 98.32M 657M 258M 3.29B 260M 254M 10.96B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- VLAP Stock
Select your edition
All financial news and data tailored to specific country editions
